Dermatology Pharmacology

Course overview

Many types of skin diseases can occur in people that range in onset and severity. Health providers need to be informed of the varied skin conditions and pharmacological therapy in order to appropriately inform patients of drug benefits and risks and to deliver comprehensive medical treatment. Dermatological treatment may be directed toward the management of an inflammatory process, comorbid medical conditions, or it may be cosmetic. There are evolving dermatology drug products and market factors that providers will need to guide patients on when addressing their skin health concerns and treatment choices. The effect of certain dermatological agents in special populations, such as during pregnancy can range from inconclusive to a known potential risk. When used in excessive amounts for prolonged periods of time, there are product warnings related to certain drug treatments for skin disease in pediatric, elderly and pregnant women. In pregnant women, for example, topical steroids have been classified as category C drugs, therefore caution must be observed to avoid harm to fetal health. More research is needed to determine the benefits and risks of dermatological agents used as cosmeceuticals and in the prevention and treatment of skin disease. No Test Required!